Takeda Will Settle Actos Lawsuits for $2.4 Billion

Thousands of Actos Lawsuits Reach Settlement Amount of $2.4 BillionAfter years of Actos lawsuits over the side effects of the Type 2 diabetes drug, Japanese pharmaceutical company Takeda recently offered a settlement the matter by distributing a total of $2.2 billion to thousands of personal injury and wrongful death lawsuits consolidated into … [Read more...]

Takeda Offers $2.2 Billion Actos Injury Settlement

Takeda Pharmaceuticals Offers to Settle Remaining Actos Injury Lawsuits for $2.2 BillionJapanese drug maker Takeda Pharmaceuticals announced that it has offered a settlement of $2.2 billion to end the remaining 8,000 lawsuits involving Actos injuries in the US.Actos was approved for sale in the United States in 1999, with sales peaking in 2011, … [Read more...]

Plaintiff Awarded $2.3 Million for Actos Bladder Cancer

Takeda Pharmaceuticals Loses Another Actos Bladder Cancer LawsuitTakeda Pharmaceuticals must pay another penalty, this time $2.3 million, for Actos bladder cancer injuries caused by the blockbuster Type 2 diabetes drug Actos, which has been tied to bladder cancer in numerous patients.On Thursday, February 12th, plaintiff John Kristufek was … [Read more...]

Actos Bladder Cancer Trials Focus On Causation

Two New Plaintiffs Assert Actos Bladder Cancer ClaimsTwo lawsuits in state court claim that Actos led to the development of bladder cancer, and in one case, the victim’s death.The family of Moshe Bitton filed a wrongful death lawsuit against Actos manufacturer Takeda Pharmaceuticals and their American subsidiaries, claiming that taking the drug … [Read more...]

Takeda Ordered to Pay for Lost Actos Files

Jury Rules Takeda Must Pay for Lost Actos FilesA jury ruled that Takeda Pharmaceuticals must pay $155,000 for its destruction or loss of files related to safety studies and information for their blockbuster Type 2 diabetes drug, Actos.Some of the missing Actos files prevented one man in a personal injury lawsuit from proving his claims that … [Read more...]

$9 Billion Actos Verdict Reduced

Judge Reduces Actos Award by 99.6%In April, a jury ruled that Takeda Pharmaceutical’s blockbuster Type 2 diabetes drug, Actos, was the cause of a plaintiff’s bladder cancer in a bellwether case representing many personal injury cases against the company.Plaintiff Terrence Allen and his wife alleged that the man took Actos as prescribed, and he … [Read more...]

Plaintiff Awarded Damages in Actos Bladder Cancer Trial

Jury Rules In Favor of Plaintiff in Actos Bladder Cancer TrialAlthough Takeda Pharmaceuticals argued that a plaintiff’s life style choices, including smoking, caused her bladder cancer, on Friday, October 3rd, ruled in favor of Frances Wisniewski’s claim in the bladder cancer trial that Actos injured her.Wisniewski was prescribed Actos to treat … [Read more...]

Takeda Accused of Putting Sales Before Actos Safety Studies

Takeda Argues It Submitted All Relevant Actos Safety Studies, but Plaintiff Claims Company Sacrificed Safety for ProfitPlaintiff Frances Wisniewski filed a personal injury lawsuit against Takeda Pharmaceuticals in 2012 in Philadelphia County Court of Common Pleas. In August 2011, Wisniewski was diagnosed with bladder cancer, and she believes that … [Read more...]

Takeda Blames Patient’s Smoking, Not Actos

Takeda Claims Patient’s Smoking Led to Bladder Cancer, Not Actos PrescriptionThe latest bellwether trial against Takeda Pharmaceuticals for injuries related to their Type 2 diabetes medication, Actos, began recently, and on Monday, September 29th, the pharmaceutical company claimed that the plaintiff’s bladder cancer was not caused by her Actos … [Read more...]

Pre-Diabetes Linked to Increased Cancer Risk

Study Links Pre-Diabetes to 15% Increased Cancer RiskA new study on diabetes, published in Diabetologia, shows a link between high blood sugar levels defined as pre-diabetes, and an increased risk of developing cancer.According to a recent report from the Centers for Disease Control, one in three Americans aged 20 or older are considered to … [Read more...]

BestLawyers.comAVBetter Business Bureau